IYBIX Performance — Nomura Balanced Fund, Institutional Class
Data updated: 2026-08-26
IYBIX returned +7.33% year to date and +13.04% over one year to Jun 2026. Annualised returns are +14.03% over 3 years and +6.44% over 5 years. The fund trailed its US Large Blend category average: $100 invested three years ago grew to $148, against $157 for the category, and to $113 over one year, against $118. Volatility over the past three years was 10.16% a year. In the 12 months to Jun 2026 the fund took in a net $219.6M, and assets reached $1.96B.
IYBIX Growth of $100
What $100 invested in Nomura Balanced Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | IYBIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $113 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $148 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $137 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $137 | $229 |
IYBIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.33% |
| 1 year | +13.04% |
| 3 years (annualised) | +14.03% |
| 5 years (annualised) | +6.44% |
IYBIX Annual Returns
Calendar-year total returns of Nomura Balanced Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.33% |
| 2025 | +12.02% |
| 2024 | +15.98% |
| 2023 | +16.50% |
| 2022 | −15.95% |
| 2021 | +0.16% |
| 2020 | +0.16% |
| 2019 (Jul–Dec) | +0.08% |
IYBIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.2% | −0.2% | −4.2% | +7.9% | +2.1% | +0.7% | — | — | — | — | — | — |
| 2025 | +2.9% | −0.5% | −3.4% | −0.4% | +3.7% | +4.2% | +0.8% | +1.1% | +2.7% | +1.1% | 0.0% | −0.4% |
| 2024 | +1.4% | +3.2% | +2.7% | −3.6% | +3.9% | +1.6% | +2.7% | +1.5% | +1.9% | −1.1% | +4.0% | −3.0% |
| 2023 | +5.5% | −2.5% | +1.8% | +0.9% | −0.8% | +4.6% | +1.6% | −1.3% | −4.1% | −2.0% | +8.0% | +4.5% |
| 2022 | −4.7% | −2.4% | +1.1% | −7.5% | +0.3% | −5.2% | +6.8% | −3.5% | −6.3% | +4.3% | +4.8% | −3.7% |
| 2021 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% | 0.0% |
| 2020 | 0.0% | 0.0% | −0.1% | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% |
| 2019 | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
IYBIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 10.16%
- 3-year Sharpe ratio: 0.94 (vs 4.5% risk-free rate)
- Best month: +8.01% (Nov 2023)
- Worst month: −4.18% (Mar 2026)
IYBIX Fund Flows
Monthly money in and out of Nomura Balanced Fund, from SEC Form N-PORT.
- 12-month net flow: $219.6M
- 12-month gross sales (incl. reinvestments): $655.3M
- Sales ÷ redemptions: 1.50×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $14.5M | $28.2M | −$13.7M |
| May 2026 | $6.7M | $30.2M | −$23.4M |
| Apr 2026 | $7.7M | $40.9M | −$33.2M |
| Mar 2026 | $13.9M | $38.1M | −$24.2M |
| Feb 2026 | $9.0M | $33.8M | −$24.8M |
| Jan 2026 | $8.7M | $35.8M | −$27.1M |
| Dec 2025 | $46.6M | $45.3M | $1.3M |
| Nov 2025 | $15.1M | $41.1M | −$26.1M |
| Oct 2025 | $18.0M | $42.7M | −$24.6M |
| Sep 2025 | $16.0M | $39.9M | −$23.9M |
| Aug 2025 | $490.0M | $30.2M | $459.8M |
| Jul 2025 | $9.1M | $29.5M | −$20.4M |
IYBIX Assets Under Management
Net assets of Nomura Balanced Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.96B |
| 2026-03-31 | $1.84B |
| 2025-12-31 | $1.98B |
| 2025-09-30 | $2.05B |
| 2025-06-30 | $1.60B |
| 2025-03-31 | $1.47B |
| 2024-12-31 | $1.53B |
| 2024-09-30 | $1.58B |
| 2024-06-28 | $1.54B |
| 2024-03-28 | $1.59B |
| 2023-12-29 | $1.54B |
| 2023-09-29 | $1.46B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.